Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
ADMET & DMPK|March 31, 2025
Antimicrobial and ADME properties of methoxylated, methylated and nitrated 2-hydroxynaphthalene-1 carboxanilidesLucia Vrablova, Tomas Gonec, Tereza Kauerova, et al.
Cancers|April 11, 2020
Role of DNA Damage Response in Suppressing Malignant Progression of Chronic Myeloid Leukemia and Polycythemia Vera: Impact of Different OncogenesJan Stetka, Jan Gursky, Julie Liñan Velasquez, et al.
ADMET & DMPK|May 2, 2025
Insight into antistaphylococcal effect of chlorinated 1-hydroxynaphthalene-2-carboxanilidesLucia Vrablova, Tomas Gonec, Petra Majerova, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Antistaphylococcal Activities and ADME-Related Properties of Chlorinated ArylcarbamoylnaphthalenylcarbamatesTomas Gonec, Dominika Pindjakova, Lucia Vrablova, et al.
International Journal of Molecular Sciences|December 11, 2022
Trifluoromethylcinnamanilide Michael Acceptors for Treatment of Resistant Bacterial InfectionsTomas Strharsky, Dominika Pindjakova, Jiri Kos, et al.
International Journal of Molecular Sciences|March 25, 2022
Study of Biological Activities and ADMET-Related Properties of Novel Chlorinated N-arylcinnamamidesTomas Strharsky, Dominika Pindjakova, Jiri Kos, et al.
American Journal of Hematology|February 6, 2024
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitorsTomas Hornak, Jiri Mayer, Petra Cicatkova, et al.
Pageof 1